CLINICAL_TRIALS
trial_result
· 2020-02-26
Clinical Trial Update: The Effects of DHA on Attention Deficit and Hyperactivity Disorder [Phase 3]
Summary
Phase 3 trial update on the effects of DHA in Attention Deficit Hyperactivity Disorder (ADHD).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: IRCCS Eugenio Medea | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED